| pubmed-article:9872508 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C0027567 | lld:lifeskim |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C0035804 | lld:lifeskim |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C0024905 | lld:lifeskim |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C0524980 | lld:lifeskim |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C1510411 | lld:lifeskim |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:9872508 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:9872508 | pubmed:dateCreated | 1999-3-18 | lld:pubmed |
| pubmed-article:9872508 | pubmed:abstractText | The tumor suppressor p53 functions at the G1/S-phase checkpoint of the cell cycle to direct cells that have accumulated somatic mutations toward apoptosis and away from mitosis. The p53 gene is commonly mutated in human cancers, but the molecular mechanisms regulating this event are not clear. The African rodent mastomys exhibits a genetic predisposition to develop gastric carcinoids derived from enterochromaffin-like (ECL) cells. The ECL cell transformation can be accelerated by acid inhibition-induced hypergastrinemia. This study evaluates the alteration of p53 during the rapid ECL cell transformation. Hypergastrinemia was generated by the irreversible histamine-2 receptor antagonist loxtidine for 8 weeks (hyperplasia) and 16 weeks (neoplasia). p53 expression was evaluated in fundic mucosa from different stages of transformation by Western blot analysis and immunohistochemistry using monoclonal antibodies against wild-type p53. RT-PCR and molecular sequence analysis of p53 were undertaken with mRNA isolated from purified ECL cells. Overproduction of the wild type of p53 was evident in ECL cells during hypergastrinemia, and the molecular characteristics of p53 were determined in naive and transformed ECL cells. p53 was mutated at the C-terminus in ECLoma induced by hypergastrinemia. Therefore, p53 is altered from overproduction to mutation during the development of hypergastrinemia-induced ECLoma and it may therefore play a role in the cell transformation. | lld:pubmed |
| pubmed-article:9872508 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9872508 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9872508 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9872508 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9872508 | pubmed:issn | 0192-0790 | lld:pubmed |
| pubmed-article:9872508 | pubmed:author | pubmed-author:KiddMM | lld:pubmed |
| pubmed-article:9872508 | pubmed:author | pubmed-author:ModlinI MIM | lld:pubmed |
| pubmed-article:9872508 | pubmed:author | pubmed-author:TengP HPH | lld:pubmed |
| pubmed-article:9872508 | pubmed:author | pubmed-author:MirDD | lld:pubmed |
| pubmed-article:9872508 | pubmed:author | pubmed-author:LuqueE AEA | lld:pubmed |
| pubmed-article:9872508 | pubmed:author | pubmed-author:EfstathiouJ... | lld:pubmed |
| pubmed-article:9872508 | pubmed:author | pubmed-author:BortecenK HKH | lld:pubmed |
| pubmed-article:9872508 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9872508 | pubmed:volume | 27 Suppl 1 | lld:pubmed |
| pubmed-article:9872508 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9872508 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9872508 | pubmed:pagination | S116-24 | lld:pubmed |
| pubmed-article:9872508 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:meshHeading | pubmed-meshheading:9872508-... | lld:pubmed |
| pubmed-article:9872508 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9872508 | pubmed:articleTitle | Gastrin-regulated expression of p53 in transformed enterochromaffin-like cells in the African rodent mastomys. | lld:pubmed |
| pubmed-article:9872508 | pubmed:affiliation | Department of Surgery, Yale University School of Medicine, New Haven, CT 06520-8062, USA. | lld:pubmed |
| pubmed-article:9872508 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9872508 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9872508 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:9872508 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
